Similar articles for PMID: 26278806

Year	Number of Results
1984	2
1990	1
1992	2
1993	1
1994	1
1995	1
1996	2
1998	2
1999	1
2000	1
2001	1
2002	1
2003	2
2004	4
2005	4
2006	3
2007	5
2008	2
2009	1
2011	1
2012	3
2013	7
2014	4
2015	4
2016	3
2018	1
2019	2
2020	2
2021	3
2022	3
2024	0

1

Three Genes to Predict Response to Chemotherapy for Bladder Cancer: Individualised Cancer Care at the Doorstep.

Rentsch CA, Stenner F, Ruiz C, Bubendorf L. Rentsch CA, et al. Eur Urol. 2015 Dec;68(6):968-9. doi: 10.1016/j.eururo.2015.07.050. Epub 2015 Aug 13. Eur Urol. 2015. PMID: 26278806 No abstract available.

2

Adjuvant Chemotherapy for Bladder Cancer: Using Population-Based Data to Fill a Void of Prospective Evidence.

Pal SK, Agarwal N, Grivas P, Choueiri T. Pal SK, et al. J Clin Oncol. 2016 Mar 10;34(8):777-9. doi: 10.1200/JCO.2015.65.4368. Epub 2016 Jan 19. J Clin Oncol. 2016. PMID: 26786913 No abstract available.

3

What has been learned from meta-analyses of neoadjuvant and adjuvant chemotherapy in bladder cancer?

[No authors listed] [No authors listed] BJU Int. 2007 Feb;99(2):464. doi: 10.1111/j.1464-410X.2007.06746_1.x. BJU Int. 2007. PMID: 17313434 No abstract available.

4

A comparison of the outcomes of neoadjuvant and adjuvant chemotherapy for clinical T2-T4aN0-N2M0 bladder cancer.

Wosnitzer MS, Hruby GW, Murphy AM, Barlow LJ, Cordon-Cardo C, Mansukhani M, Petrylak DP, Benson MC, McKiernan JM. Wosnitzer MS, et al. Cancer. 2012 Jan 15;118(2):358-64. doi: 10.1002/cncr.26278. Epub 2011 Jun 29. Cancer. 2012. PMID: 21717438 Free article.

5

Neoadjuvant chemotherapy for bladder cancer.

Sonpavde G, Lerner SP. Sonpavde G, et al. Oncology (Williston Park). 2007 Dec;21(14):1673-81; discussion 1686-8, 1691, 1694. Oncology (Williston Park). 2007. PMID: 18247016 Free article. Review.

6

The optimal neoadjuvant chemotherapy regime for muscle-invasive bladder cancer: still an open question?

Carus A, Holmsten K, Pappot H, Ullén A. Carus A, et al. Acta Oncol. 2022 Dec;61(12):1515-1516. doi: 10.1080/0284186X.2022.2153620. Epub 2022 Dec 9. Acta Oncol. 2022. PMID: 36484326 No abstract available.

7

Neoadjuvant methotrexate, vinblastine, doxorubicin and cisplatin for histologically proven lymph node positive bladder cancer.

Nieuwenhuijzen JA, Bex A, Meinhardt W, Kerst JM, Schornagel JH, VAN Tinteren H, Horenblas S. Nieuwenhuijzen JA, et al. J Urol. 2005 Jul;174(1):80-5. doi: 10.1097/01.ju.0000162018.40891.ba. J Urol. 2005. PMID: 15947583

8

Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: A Systematic Review and Two-Step Meta-Analysis.

Yin M, Joshi M, Meijer RP, Glantz M, Holder S, Harvey HA, Kaag M, Fransen van de Putte EE, Horenblas S, Drabick JJ. Yin M, et al. Oncologist. 2016 Jun;21(6):708-15. doi: 10.1634/theoncologist.2015-0440. Epub 2016 Apr 6. Oncologist. 2016. PMID: 27053504 Free PMC article. Review.

9

[Neoadjuvant chemotherapy with MVAC in bladder carcinoma: Is the feasibility really established? Of: Benadiba et al.: Neoadjuvant chemotherapy in muscular invasive bladder cancer: Complications and consequences on cystectomy, Pr Urol 2015; 25: 549-554].

Coquard R. Coquard R. Prog Urol. 2015 Dec;25(16):1171-2. doi: 10.1016/j.purol.2015.07.008. Epub 2015 Sep 26. Prog Urol. 2015. PMID: 26420677 French. No abstract available.

10

Nonplatinum therapy in advanced bladder cancer.

Srinivas S, Colocci N. Srinivas S, et al. Expert Rev Anticancer Ther. 2006 Jun;6(6):887-94. doi: 10.1586/14737140.6.6.887. Expert Rev Anticancer Ther. 2006. PMID: 16761932 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

59 results

Results by year